LVMH’s Thelios eyewear unit announced its acquisition of the high-end sunglasses brand, Vuarnet which is owned by French manufacturer Sporoptic Pouilloux S.A. but was bought by NEO Investment Partners in 2015. Thelios is now buying the iconic sunglasses label from the investment firm.
Vuarnet is the first-ever brand that Thelios has acquired, so it is thrilled to add it to its own portfolio. The company designs, makes, and supplies eyewear pieces to most of LVMH’s fashion houses, including Kenzo, Fendi, Dior, Loewe, Celine, and Stella McCartney. With Vuarnet now under its wing, Thelios is looking to augment its presence in the luxury eyewear market.
Thélios said that Vuarnet, which has more than 60 years of heritage and pioneering manufacturing of mineral lenses, would “perfectly” blend with its current portfolio as the brand is positioned at the crossroads of outdoors and fashion.
Fashion United UK reported that Vuarnet has over 60-year history of pioneering the production of mineral lenses. It is such an iconic name in the eyeglasses industry and Thelios is planning to “restore the brand's former glory."
The eyewear division of the LVMH Group also wants to scale up the product quality of Vuarnet’s products and develop it more beyond the boundaries of innovation. For its advancement, the French eyewear maker will use Thélios’ resources such as its research and development capabilities and technical expertise. It will also take advantage of Thelios’ global reach to push its own growth and expansion at the global level.
“We are thrilled to announce the acquisition of Vuarnet, becoming Thélios’ first proprietary brand,” Thelios’ chief executive officer, Alessandro Zanardo, said in a statement, “Vuarnet is a legendary brand, with a unique history that deserves to be preserved and perpetuated. Its iconic design, its unique know-how on mineral lenses and its strong brand values, are a perfect match with our ethos and positioning.”
Photo by: Annie Williams/Unsplash


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Australian Pension Funds Boost Currency Hedging as Aussie Dollar Strengthens
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves
Asian Currencies Stay Rangebound as Yen Firms on Intervention Talk 



